Wordt geladen...
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
BACKGROUND: Experience using post-transplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation (HSCT) from matched sibling donors (MSD) or unrelated donors (UD) is limited and with controversial results. The study aim was to evaluate PT-...
Bewaard in:
| Gepubliceerd in: | J Hematol Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5855999/ https://ncbi.nlm.nih.gov/pubmed/29544522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0586-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|